Bicycle Therapeutics Plc Income Statement

1Y3Y5Y7Y10YAll
Download Data
Income Statement Dec2017 Dec2018 Dec2019 Dec2020 Dec2021 Dec2022 Dec2023 Dec2024
Revenue & cost
Revenue 2.06M7.14M13.80M10.39M11.70M14.46M5.30M1.20M
Gross Profit 2.06M7.14M13.80M10.39M11.70M14.46M5.30M1.20M
Operating items
Research & Development 11.87M20.76M25.54M33.15M44.88M81.61M156.50M172.97M
Wages, Salaries and Other 13.95M18.98M23.50M
Selling, General & Administrative 6.41M8.12M14.56M29.20M32.44M49.51M60.43M72.18M
Restructuring Costs 8.78M9.14M9.05M
Other Operating Expenses -8.78M-9.14M-9.05M
Operating Expenses 18.27M28.88M40.10M62.35M77.31M131.12M216.92M245.15M
Operating Income -16.21M-21.75M-26.30M-51.96M-65.62M-116.65M-189.95M-209.87M
EBIT -16.21M-21.75M-26.30M-51.96M-65.62M-116.65M-189.95M-209.87M
Non-operating items
Interest & Investment Income 0.05M0.17M0.81M0.68M0.12M5.76M14.00M34.28M
Other Non Operating Income -0.12M-0.67M-5.38M-0.60M-0.60M-1.00M
Non Operating Income -0.12M-0.67M-5.38M0.23M-2.86M2.41M10.74M36.08M
Net income details
EBT -16.32M-22.24M-31.91M-52.52M-69.55M-116.28M-182.98M-179.61M
Tax Provisions 0.09M-0.40M-0.30M-0.72M-1.70M3.45M-1.85M-4.80M
Profit After Tax -16.30M-21.85M-30.61M-51.01M-66.82M-112.72M-180.70M-169.03M
Income from Continuing Operations -16.40M-21.84M-31.61M-51.80M-67.85M-119.73M-181.13M-174.81M
Consolidated Net Income -16.40M-21.84M-31.61M-51.80M-67.85M-119.73M-181.13M-174.81M
Income towards Parent Company -16.40M-21.84M-31.61M-51.80M-67.85M-119.73M-181.13M-174.81M
Net Income towards Common Stockholders -16.26M-21.85M-30.61M-51.01M-66.82M-112.72M-180.66M-169.03M
Additional items
EPS (Basic) -0.00M-0.00M-0.00M-0.00M-0.00M-0.00M-0.00M-0.00M
EPS (Weighted Average and Diluted) -0.00M-0.00M-0.00M-0.00M-0.00M-0.00M
Shares Outstanding (Weighted Average) 17.70M17.99M21.30M29.40M29.69M42.42M69.05M
Shares Outstanding (Diluted Average) 11.05M19.15M25.06M29.66M35.59M58.21M
EBITDA -13.90M-23.67M-30.39M-52.67M-67.01M-108.94M-182.35M-167.61M
Tax Rate 0.00M0.00M0.00M0.00M0.00M0.00M